top of page

Generis Partner with Cognizant to Deliver Innovative Information Management and Structured Content A

Updated: Jul 5, 2021

– Strategic Collaboration to Expand Global Presence –

30 Nov 2020, London, Generis, a leader in content and information management systems for regulated industries, announces its strategic partnership with Cognizant, a global provider of information technology, consulting, and business process services, to deliver innovative information management solutions for Life Sciences.

This partnership will see Cognizant leverage Generis’ flagship product, the CARA Life Science Platform, to enable clients to streamline their business processes on one comprehensive Workspace that covers: RIM / Regulatory and Quality / QMS and Safety / PV and Clinical, as well as enterprise-wide functionality such as Component-Based / Structured Content Authoring.

CARA is an innovative enterprise workspace designed specifically for Life Sciences which offers a simple, unified way of working with business-critical content and information.  The solution enables rapid, codeless implementation of regulated business processes for managing content and data securely and seamlessly across the business, with connectivity to modern productivity tools (e.g., Office 365, DocuSign, Slack, Google Docs/Drive, SAP and many others). With a standardisation of processes across the business, CARA allows organisations to ensure consistent rules for security, versioning, lifecycles and workflows. The platform delivers secure, versatile and scalable solutions both in the cloud as SaaS or on premise.

“We are delighted to be working with such a forward-thinking organisation. Cognizant understands the business problems that our mutual customers face, and how to address those in a way that goes beyond the standard IT implementation partner approach”, said James Kelleher, CEO of Generis. “This strategic partnership will enable our existing and new customers to make the most of the possibilities within the CARA platform.”

CARA is already widely deployed in the pharmaceutical, biotech, medical device, and other Life Sciences industries where strict regulatory compliance must be maintained.

Customers include 60% of the Top 20 largest global life science companies as well as over 500,000 users globally.

“Cognizant is a proven leader in Life Sciences”, said Venu Mallarapu, Director and Global Life Sciences R&D Market Lead. “The CARA Platform represents a best-in-class solution for many of the business use cases our Life Science customers face and will help meet their regulated content and information management needs. Through spearheaded technology innovation, CARA delivers the utmost value by balancing a next generation SaaS platform with lower total cost of ownership. We are excited to partner with Generis to deliver transformative experience in regulated content management to our joint customers across the globe”


About Generis:   

Generis is a global leader in information management systems, specialising in proven solutions for regulated industries. Established in 1997 as a consultancy group, Generis has since grown and developed alongside its flagship product CARA. Our mission is to provide a system which is seamless and user-friendly; a dedicated. Currently counting over 500,000 users across numerous industries worldwide, including 8 of the 10 largest Life Science companies, the CARA Workspace and the CARA Life Sciences Platform offer solutions for different use cases from Quality and RIM, to Labelling and Marketing.

About Cognizant:

Cognizant (Nasdaq-100: CTSH) is one of the world’s leading professional services companies, transforming clients’ business, operating, and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 194 on the Fortune 500 and is consistently listed among the most admired companies in the world. Learn how Cognizant helps clients lead with digital at or follow us @Cognizant.

bottom of page